Merck (HAM:6MK) FFO


HAM:6MK Merck & Co Inc HAM:6MK
78 GF Score
Price €112.14
GF Value €103.21
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Merck FFO?

FFO (Funds from operations) only applies to REITs.

HAM:6MK
78GF Score
Merck & Co Inc HAM:6MK
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Merck (HAM:6MK) Overvalued in 2026?

Based on GuruFocus' analysis, Merck stock appears to be overvalued. The current stock price of €112.14 is trading 8.7% above its estimated GF Value™ of €103.21. GuruFocus considers Merck to be Fairly Valued.

Key valuation signals for HAM:6MK:

  • FFO:
  • GF Value™: €103.21 vs. price of €112.14 (8.7% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the HAM:6MK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Merck Business Description

Address 126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
78GF Score

Get the complete analysis for HAM:6MK

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€112.14
Price
€103.21
GF Value